A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia

INTRODUCTION: Behavioural variant frontotemporal dementia (bvFTD) is a neurodegenerative disorder often neuropathologically associated with the accumulation of abnormally hyperphosphorylated tau, for which there is currently no disease-modifying treatment. Previous work by our group has shown sodium...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Vivash, Lucy, Malpas, Charles B, Churilov, Leonid, Walterfang, Mark, Brodtmann, Amy, Piguet, Olivier, Ahmed, Rebekah M, Bush, Ashley I, Hovens, Christopher M, Kalincik, T, Darby, David, Velakoulis, Dennis, O'Brien, Terence J
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Neurology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7670941/
https://ncbi.nlm.nih.gov/pubmed/33199422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-040100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados